Therapex Co Ltd

We track 1 ClinicalTrials.gov studies led by Therapex Co Ltd. The portfolio skews toward Phase 2 (1 trials).

1 clinical trials sponsored by Therapex Co Ltd.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials by Therapex Co Ltd

An Open Label, Multicenter, Phase 1/2 Study to Explore the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of TRX-221 in the Treatment of Patients With EGFR Mutant NSCLC Who Progressed Following Prior Therapy With EGFR TKI

NCT06186076 · TERMINATED · Phase 2

Frequently Asked Questions

How many clinical trials does Therapex Co Ltd sponsor?

Therapex Co Ltd currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does Therapex Co Ltd research?

Therapex Co Ltd conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Therapex Co Ltd recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More